Treatment of fibrodysplasia ossificans progressiva

MYPI2025005306A0Undetermined Publication Date: 2021-07-08REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025005306
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-09-22
Filing Date
2021-01-08
Publication Date
2021-07-08
Patent Text Reader

Abstract

Methods for treating fibrodysplasia ossificans progressiva (FOP) in human subjects are provided. Such methods involve administering to a subject having FOP a therapeutically effective amount of an Activin A antagonist, such as an antibody against Activin A.
Need to check novelty before this filing date? Find Prior Art